Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Five (Non-COVID) Clinical Trial Hits Of 2021

Jan 05 2022

• By Alexandra Shimmings

Hit the target — • Source: Alamy

Related Content

AstraZeneca And Sanofi March Ahead With Positive Phase III RSV Data

Apr 26 2021

Lilly's Tirzepatide Shows Up Novo's Ozempic In Head-To-Head Diabetes Trial

Mar 04 2021

BI/Lilly's Jardiance Crowned As Heart Failure Game Changer After EMPEROR-Preserved

Aug 30 2021

Pfizer's Oral Abroctinib Bests Injectable Dupixent In Atopic Dermatitis Trial

Aug 30 2021

Enhertu Poised To Rewrite The Standard Of Care After ESMO

Sep 20 2021

Pfizer’s RSV Vaccine Springs Another Surprise, This Time In Maternal Use

Nov 01 2021

Pfizer Buys Arena For $6.7bn In Bid To Diversify In Inflammation & Immunology

Dec 13 2021

Lilly Aims For Earlier Treatment With Novel Diabetes Drugs

Jul 07 2021

Related Companies

Boehringer Ingelheim GmbH

Eli Lilly and Company

Novartis AG

AstraZeneca PLC

Sanofi

Pfizer Inc.

Daiichi Sankyo Co., Ltd.

Roche Holding AG

Arena Pharmaceuticals, Inc.

Additional Topics

Clinical Trials Companies Research & Development Innovation Cancer Cardiovascular Infectious Diseases Metabolic Disorders Dermatology Inflammation BioPharmaceutical

More from Innovation

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window